Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Duzallo (allopurinol and lesinurad) for the Treatment of Hyperuricemia Associated with Gout

Drug (Brand / Generic)

Duzallo / allopurinol and lesinurad

Developer

Ironwood Pharmaceuticals

Therapy Class

Urate transporter-1 (URAT-1) inhibitor and xanthine oxidase inhibitor (XOI)

Current Indication

Hyperuricemia associated with Gout

Market Sector

Urology

Development Status

Approved in the US
Expand

Go Top